Teacher Retirement System of Texas Has $2.40 Million Stake in iRadimed Corporation $IRMD

Teacher Retirement System of Texas decreased its stake in iRadimed Corporation (NASDAQ:IRMD) by 21.7% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 40,207 shares of the medical equipment provider’s stock after selling 11,152 shares during the period. Teacher Retirement System of Texas’ holdings in iRadimed were worth $2,404,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. First Horizon Advisors Inc. raised its position in iRadimed by 78.7% in the 1st quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider’s stock valued at $27,000 after purchasing an additional 226 shares during the last quarter. US Bancorp DE raised its position in iRadimed by 132.7% in the 1st quarter. US Bancorp DE now owns 1,436 shares of the medical equipment provider’s stock valued at $75,000 after purchasing an additional 819 shares during the last quarter. Quantbot Technologies LP bought a new position in iRadimed in the 1st quarter valued at $78,000. Comerica Bank raised its position in iRadimed by 21.4% in the 1st quarter. Comerica Bank now owns 2,288 shares of the medical equipment provider’s stock valued at $120,000 after purchasing an additional 404 shares during the last quarter. Finally, State of Wyoming raised its position in iRadimed by 11.3% in the 1st quarter. State of Wyoming now owns 3,013 shares of the medical equipment provider’s stock valued at $158,000 after purchasing an additional 307 shares during the last quarter. Institutional investors and hedge funds own 92.34% of the company’s stock.

Analyst Ratings Changes

IRMD has been the subject of several research analyst reports. Weiss Ratings reiterated a “buy (b)” rating on shares of iRadimed in a research report on Friday. Wall Street Zen downgraded iRadimed from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 26th. Finally, Roth Capital set a $90.00 price objective on iRadimed in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating and two have given a Buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $81.00.

Insiders Place Their Bets

In other news, CEO Roger E. Susi sold 5,000 shares of the business’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $77.69, for a total transaction of $388,450.00. Following the completion of the sale, the chief executive officer owned 2,327,500 shares in the company, valued at $180,823,475. The trade was a 0.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Monty K. Allen sold 1,102 shares of the business’s stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $69.10, for a total value of $76,148.20. Following the sale, the director owned 19,898 shares of the company’s stock, valued at approximately $1,374,951.80. The trade was a 5.25% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 36,102 shares of company stock valued at $2,623,848. 36.80% of the stock is currently owned by corporate insiders.

iRadimed Stock Up 0.5%

IRMD stock opened at $76.81 on Monday. The company has a market cap of $976.64 million, a P/E ratio of 47.41 and a beta of 1.02. iRadimed Corporation has a twelve month low of $46.86 and a twelve month high of $80.64. The business has a fifty day moving average of $73.14 and a 200-day moving average of $63.84.

iRadimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.